Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 16

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Apr 28, 2006; 12(16): 2610-2614
Published online Apr 28, 2006. doi: 10.3748/wjg.v12.i16.2610

Table 1 Clinical and pathologic characteristics of the patients

Variables	Control group(n = 25)	Study group(n = 23)
Age (yr): Median (range)	62 (36-70)	62 (40-72)
Sex
Male	17	14
Female	8	9
Dukes’ stage of initial lesion
A	1	1
B	7	5
C	17	17
Tumor pathologic type
Well and moderately differentiated adenocarcinoma	19	17
Mucinous adenocarcinoma	4	3
Signet ring cell carcinoma	2	3
Recurrent sites
Presacral	23	21
Pelvic sidewall	2	2

No significant differences in clinical or pathologic variables between the two groups were observed.

Citation: Hu JB, Sun XN, Yang QC, Xu J, Wang Q, He C. Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer. World J Gastroenterol 2006; 12(16): 2610-2614
URL: https://www.wjgnet.com/1007-9327/full/v12/i16/2610.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i16.2610

Hu JB, Sun XN, Yang QC, Xu J, Wang Q, He C. Three-dimensional conformal radiotherapy combined with FOLFOX4 chemotherapy for unresectable recurrent rectal cancer. World J Gastroenterol 2006; 12(16): 2610-2614 [PMID: 16688811 DOI: 10.3748/wjg.v12.i16.2610]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.